We're happy to support the Inova Cardiovascular Symposium this weekend! Stop by our booth to learn how #Barostim can help improve quality of life for #HFrEF patients. ISI: http://barost.im/ISI
CVRx | Barostim
Medical Equipment Manufacturing
Minneapolis, MN 12,758 followers
CVRx’s Barostim is a breakthrough technology that stimulates the body’s natural baroreflex to treat heart failure
About us
CVRx is a commercial stage, public (NASDAQ: CVRX) medical devices company located in Minneapolis, Minnesota. The company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. Barostim™ triggers carotid baroreceptors - the body’s own natural blood flow regulation system - which signals the brain to regulate cardiovascular function. Patient Stories on CVRx: The accounts and quotes of patients are genuine and documented. These stories represent a unique individual experience and does not provide any indication, guide, warranty or guarantee as to the response other people may have to CVRx technologies. Barostim is a prescriptive device. For a list of all potential benefits and risks go to www.cvrx.com/benefit-risk-analysis/
- Website
-
http://www.cvrx.com
External link for CVRx | Barostim
- Industry
- Medical Equipment Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Minneapolis, MN
- Type
- Public Company
- Founded
- 2001
Locations
-
Primary
Minneapolis, MN 55445, US
-
Employees at CVRx | Barostim
Updates
-
Save the date for a lunchtime panel discussion about #Barostim at #HFSA2024. An experienced faculty will discuss patient selection, patient care pathways, and real world strategies for incorporating Barostim into a comprehensive #heartfailure program. Add to calendar: https://barost.im/4dEAMB6
-
We're proud to partner with Dr. Constantin Witt, Dr. Martin Oberhoffer, PD Dr. Mansur Duran, Dr. Alexander Petrov, PD Dr. Axel Kloppe, Chief of Cardiology, and the team at Marienhospital Gelsenkirchen on their first #Barostim implant. #heartfailure #cardiology #vascularsurgery
-
-
We’re pleased to announce two new appointments to our Board of Directors – Kevin Ballinger and Mitch Hill. "We are thrilled to welcome Kevin and Mitch to our Board of Directors," said Kevin Hykes, President and CEO of CVRx. "Their extensive experience in the medical device industry, coupled with their strong track records driving growth and innovation, will be invaluable as we continue to expand the adoption of our Barostim therapy. Kevin's deep understanding of interventional cardiology and Mitch's financial acumen in high-growth healthcare companies align perfectly with our strategic goals.” Learn more: https://barost.im/3ZbN53o
-
We were honored to support Dr. Jessica Green, Dr. Ryan Hagino, Dr. Carol Lai, Kim Koyanagi, NP and the team at Straub Medical Center on their first #Barostim implant. Their patients now have access to a novel device therapy option to improve #heartfailure symptoms.
-
-
We are pleased to share a new publication in JACC Journals JACC: Heart Failure by Dr. Sam Sears and his colleagues demonstrating the details of long-term quality of life improvements with #Barostim in patients with NYHA Class II or III symptoms and an LVEF ≤35% The authors report that patients had persistent improvement in both the emotional and physical components of the Minnesota Living with Heart Failure Questionnaire after 2 years follow-up. Patients’ ability to work around the house, sleep, do things with friends and family were improved along with improved shortness of breath and fatigue. Emotionally, patients were less depressed, had improved locus of control and did not feel as if they were a burden on friends and family. Even the EuroQual-5D instrument demonstrated long-term benefit with increase mobility and ability to perform usual activities along with decreased pain and discomfort. ISI: barost.im/ISI https://lnkd.in/gRNuu2_R
Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure Trial
sciencedirect.com
-
After being diagnosed with congestive #heartfailure, Doris experienced worsening HF symptoms for years, including trouble walking, constant fatigue, difficulty breathing and swelling. Considered a good candidate for #Barostim, Doris didn’t hesitate for the opportunity to improve her quality of life. Since receiving the therapy, Doris has resumed enjoying the activities she loves the most with a newfound energy and independence. ISI: http://barost.im/ISI
-
Happening tonight! Tune in to learn about #Barostim for #HFrEF patients from Katrina Baxter, MSN, NP-C, CHFN and Jessica Griffiths, PA-C. Register here: https://lnkd.in/gVP8vM2h
-
In a new article published in Endovascular Today on #Barostim, Dr. John F. Eidt and Dr. Jean Marie Ruddy share surgical considerations, patient outcomes, and care pathways on the extravascular procedure for #HFrEF patients. Read here: https://lnkd.in/gfw3RP-f ISI: http://barost.im/ISI
Physician Experience and Surgical Techniques With Baroreflex Activation Therapy: A Novel Extravascular Procedure for Heart Failure Patients - Endovascular Today
evtoday.com
-
The VA continues to expand access to #Barostim - a novel device therapy option - for Veterans suffering from #heartfailure. We were proud to support Dr. Michael Soult and Dr. Mingxi Dennis Yu and the team at Edward Hines, Jr. VA Hospital on their first Barostim implant.
-